WVE Stock Analysis: Buy, Sell, or Hold?
WVE - Wave Life Sciences Ltd. Ordinary Shares
$5.74
0.23 (4.17%)
▲
5d:
-3.04%
30d:
-8.31%
90d:
-21.58%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Smart Money Accumulation
None View Scanner →
Strength: 5.6/10
Get Alerted When WVE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: WVE shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: WVE shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: WVE is currently trading at $5.74, which is considered slightly low relative to its 30-day fair value range of $5.68 to $6.14.
Technical Outlook: Technically, WVE is in a downtrend. Immediate support is located at $5.36, while resistance sits at $6.12. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: WVE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $19.62 (+241.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, WVE is in a downtrend. Immediate support is located at $5.36, while resistance sits at $6.12. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: WVE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $19.62 (+241.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$5.68 -
$6.14
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.2%)
- BULLISH: Trading 241.9% below Wall St target ($19.62)
Trading Range Analysis
30-Day Trading Range
$5.68 -
$6.14
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$5.36
Resistance Level
$6.12
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.03
Wall Street Target
$19.63
(+241.9%)
Revenue Growth (YoY)
-73.9%
Share & Embed Analysis
Last updated: August 03, 2026 8:01 PM ET
Data refreshes hourly during market hours. Next update: 9:01 PM
Data refreshes hourly during market hours. Next update: 9:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WVE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Chris Francis
SELL
33194 shares
2026-02-26
Chandra Vargeese
SELL
3228 shares
2026-02-09
Chris Francis
SELL
1883 shares
2026-02-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$386 | 43 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
Advanced WVE Option Strategies
Professional options setups generated by AI based on today's WVE price and gamma walls.
